Press Room

bonus 1a

Press Releases 2023

Bonus BioGroup (TASE: BONS) is a clinical-stage Israeli biotechnology company, engaged in research and development of biomedical tissue-engineered and cell therapy products. Bonus Biogroup is pleased to announce entering an advanced stage in a joint trial in partnership with the Israel Institute for Biological Research (the "IIBR"). This study explores,…
The drug MesenCure reduced life-threatening cytokine release syndrome, which occurred as a result of immunotherapy for the treatment of cancer Bonus BioGroup (TASE: BONS) is a clinical-stage Israeli biotechnology company, engaged in research and development of biomedical tissue-engineered and cell therapy products. Bonus Biogroup is pleased to announce that Jackson…
Collaboration with one of Europe's leading research centers in personalized medicine aims to accelerate clinical development. Bonus BioGroup (TASE: BONS) is a clinical-stage Israeli biotechnology company, engaged in research and development of biomedical tissue-engineered and cell therapy products. Bonus Biogroup is delighted to announce the signing of a strategic cooperation…
Orthopedic Surgeons to Showcase Successful Treatment of Bone Deficiencies with BonoFill, a Live Human Bone Graft by Bonus Biogroup Bonus BioGroup (TASE: BONS) is a clinical-stage Israeli biotechnology company, engaged in research and development of biomedical tissue-engineered and cell therapy products. Bonus Biogroup is pleased to announce that orthopedic surgeons…
The Israel Ministry of Health certified the facility and process for producing the investigational drug MesenCure to comply with Good Manufacturing Practices (GMP) according to the recommendations of the World Health Organization. Bonus BioGroup (TASE: BONS) is a clinical-stage Israeli biotechnology company, engaged in research and development of biomedical tissue-engineered…

INFORMATION FOR INVESTORS  |  CAREER OPPORTUNITIES  |  INFORMATION FOR PATIENTS   |   RESEARCH COLLABORATIONS & BUSINESS DEVELOPMENT INQUIRIES

INFORMATION FOR INVESTORS

CAREER OPPORTUNITIES

INFORMATION FOR PATIENTS

RESEARCH COLLABORATIONS & BUSINESS DEVELOPMENT INQUIRIES

BONUS BIOGROUP LTD.

Terms of Use | Privacy Policy

MAIL ICON  info@bonus-bio.com

MAIL ICON  +972 (0)73 206 7104

MAIL ICONMatam Advanced Technology
Park P.O.B 15143 Haifa 31905 Israel

you tube linkedin facebook twitter

© 2022 Bonus BioGroup Ltd. Created By Netron Israel Ltd

Please publish modules in offcanvas position.